![Applied BioMath Applied BioMath Logo](/images/default-source/sponsor-logos/a-g/applied-biomath-logo.png)
De-Risking Drug Discovery with Applied BioMath Assess™, a New Early Feasibility Assessment Tool for Biotherapeutics
The steep cost of developing a new therapeutic to market. Early feasibility assessment (EFA) has proven to
drastically improve the efficiency of pharmaceutical R&D and should be integrated into every drug R&D program. Applied BioMath Assess*, a new web-based application that provides the necessary models and analyses via an intuitive interface,
makes this integration a reality.
*Patent pending